Dr. Steffi Oesterreich and Leigh Pate became good friends (and Leigh became a fierce yet humble ILC patient advocate). They had many phone calls and some in-person meetings discussing how to drive ILC research forward. Other patients who had joined the 1st ILC Symposium in 2016 in Pittsburgh joined in (such as Lori Pettiti) – and the Lobular Breast Cancer Alliance (LBCA) was born. Dr. Steffi Oesterreich served as Chair of the Scientific Advisory Board until 2022.
Founding of LBCA, the first patient advocacy group focused on ILC.
